Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – Medical Xpress
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
“We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition to standard…
-
General21 hours agoCoalition seeks to rebuild ties with Indian community
-
Business21 hours agoHow to retire in your 50s with ASX shares
-
Noosa News23 hours agoNational Drought Forum convenes in SA to put policy under scrutiny
-
Noosa News21 hours agoGold Coast fans ‘galvanized’ behind the Suns ahead of AFL QClash semifinal